Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more
Darya-Varia Laboratoria Tbk (DVLA) - Total Liabilities
Latest total liabilities as of June 2025: Rp904.97 Billion IDR
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has total liabilities worth Rp904.97 Billion IDR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Darya-Varia Laboratoria Tbk - Total Liabilities Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Darya-Varia Laboratoria Tbk Competitors by Total Liabilities
The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jasper Mining Corporation
PINK:JAMGF
|
USA | $10.87 Million |
|
Chicago Rivet & Machine Co
NYSE MKT:CVR
|
USA | $4.01 Million |
|
Ikena Oncology Inc
NASDAQ:IKNA
|
USA | $10.26 Million |
|
Eastern Power Group Public Company Limited
BK:EP
|
Thailand | ฿5.86 Billion |
|
North Energy ASA
OL:NORTH
|
Norway | Nkr70.00 Million |
|
Peloton Minerals Corporation
OTCQB:PMCCF
|
USA | $2.30 Million |
|
ThroughTek Co., Ltd.
TWO:6565
|
Taiwan | NT$136.65 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Darya-Varia Laboratoria Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Darya-Varia Laboratoria Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual total liabilities of Darya-Varia Laboratoria Tbk from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp712.57 Billion | +11.73% |
| 2023-12-31 | Rp637.74 Billion | +5.32% |
| 2022-12-31 | Rp605.52 Billion | -14.12% |
| 2021-12-31 | Rp705.11 Billion | +6.77% |
| 2020-12-31 | Rp660.42 Billion | +26.06% |
| 2019-12-31 | Rp523.88 Billion | +8.56% |
| 2018-12-31 | Rp482.56 Billion | -8.01% |
| 2017-12-31 | Rp524.59 Billion | +16.11% |
| 2016-12-31 | Rp451.79 Billion | +12.17% |
| 2015-12-31 | Rp402.76 Billion | +47.09% |
| 2014-12-31 | Rp273.82 Billion | -0.56% |
| 2013-12-31 | Rp275.35 Billion | +18.10% |
| 2012-12-31 | Rp233.14 Billion | +16.36% |
| 2011-12-31 | Rp200.37 Billion | -6.15% |
| 2010-12-31 | Rp213.51 Billion | -6.64% |
| 2009-12-31 | Rp228.69 Billion | +76.17% |
| 2008-12-31 | Rp129.81 Billion | +31.52% |
| 2007-12-31 | Rp98.70 Billion | -31.94% |
| 2006-12-31 | Rp145.03 Billion | -9.37% |
| 2005-12-31 | Rp160.03 Billion | +42.69% |
| 2004-12-31 | Rp112.15 Billion | +12.06% |
| 2003-12-31 | Rp100.08 Billion | +4.43% |
| 2002-12-31 | Rp95.84 Billion | -55.81% |
| 2001-12-31 | Rp216.89 Billion | +5.23% |
| 2000-12-31 | Rp206.10 Billion | -- |